{
    "title": "Marinus genetic epilepsy drug meets main goal of late-stage study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8732445/Marinus-genetic-epilepsy-drug-meets-main-goal-late-stage-study.html",
    "date": "2020-09-14",
    "keywords": [
        "cdd",
        "treatment",
        "drug",
        "ganaxolone",
        "goal",
        "seizure",
        "frequency",
        "latestage",
        "trial",
        "company",
        "monday",
        "type",
        "epilepsy",
        "cdkl5",
        "deficiency",
        "disorder",
        "difficulttocontrol",
        "impairment",
        "reduction",
        "decrease",
        "placebo",
        "studys",
        "significance",
        "talk",
        "feed",
        "addition",
        "refractory",
        "status",
        "epilepticus",
        "condition",
        "costsharing",
        "contract",
        "research",
        "development",
        "authority",
        "barda",
        "study",
        "rse",
        "marinus",
        "marketing",
        "application",
        "health",
        "regulator",
        "mid2021",
        "radnor",
        "eu",
        "approval",
        "end",
        "quarter",
        "reporting",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "aditya",
        "soni"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}